TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-confidence in Clinical Decision Making
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety in Clinical Decision Making
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of Anti-AAV8 Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of Anti-AAV9 Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of variations interpreted as responsible for the Mitochondrial diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported digestive comfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in daily self-reported digestive comfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of postoperative Emergence Agitation
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of using an Oral Nutritional Supplement (ONS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mental health hospitalization rate
Endpoint domain: Mortality/survival
Primary endpoint: Five Self-harm Behaviour Groupings Measure (5S-HM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fluorodeoxyglucose (FDG) positron emission tomography (PET) brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Dementia Rating scale score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Assessment of cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rosacea clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VISIA Red Area score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sensitivity of the Pocket CARE in detecting pre-cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity of the Pocket CARE in detecting pre-cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Positive Predictive Value (PPV) of the Pocket CARE in detecting pre-cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Enrollment Effectiveness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Monthly recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of neurogenic bladder spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent change in N-Acetyl Aspartate (NAA) in the cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 3 meter back walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epsworth Sleepiness Scale (ESS) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total duration of Stage 3 Non Rapid Eye Movement (NREM) sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Total duration of Stage 4 Rapid Eye Movement (REM) sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Number of participants with Preterm Delivery
Endpoint domain: Mortality/survival
Primary endpoint: Number of participant with Premature Spontaneous Rupture of the Membranes
Endpoint domain: Mortality/survival
Primary endpoint: Number of Infant Deaths
Endpoint domain: Mortality/survival
Primary endpoint: Seroconversion rate of the neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Negr1 gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial perfusion imaging (MPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial blood flow (MBF) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maintenance of volume in the maxillary sinus region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound Fraction (fu)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percent correct
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bayley Scales of Infant and Toddler Development III
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Engagement with the VR program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with the VR game
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intention to change
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Biomarker analysis from exhaled breath condensate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Immune pathway activation in tumor-draining lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline Waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of matrix metalloproteinase (MMP)-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental Stress Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in immunosuppressive drugs-associated diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with excellent/good cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: immunomodulation effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: success rate of cord blood collection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in NLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in creativity performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of completion of all preoperative and operative therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrence-free survival at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Mature oocyte yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: GI Endoscopic complications
Endpoint domain: Adverse events/effects
Primary endpoint: remission maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in thin ideal internalization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of proinflammatory cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in retention rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Range of compensation motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cyber-Sexual Harassment survey score
Endpoint domain: Adverse events/effects
Primary endpoint: Peer-to-peer physical and sexual violence in school and community survey score
Endpoint domain: Adverse events/effects
Primary endpoint: Witnessing intimate partner violence (IPV) survey score
Endpoint domain: Adverse events/effects
Primary endpoint: IPV victimization and/or perpetration as assessed by Somalia National Survey
Endpoint domain: Adverse events/effects
Primary endpoint: Non-partner physical and/or sexual violence victimization as assessed by the National Somalia Survey
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Meibomian gland score (MGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary gaze orientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Hammersmith Infant Neurological Examination (HINE) Section 2 Motor Milestones Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell-free DNA, cell-free RNA and exosomal RNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF-DA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of serious metabolic acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sperm DNA Fragmentation Assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Decision-making abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in child attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in caregiver- and child-reported use of punishment
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pneumococcal Vaccine Antibody Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherence to the intervention (training program and CN-NINM) in percent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with CN-NINM-related adverse events as assessed by a questionnaire
Endpoint domain: Adverse events/effects
Primary endpoint: Positive predictive value at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity Rate at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from attitudes towards the elderly
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from perception of individualized care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from knowledge test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Nursing History Knowledge Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants achieving HBsAg lower than LLOQ and HBV DNA lower than LLOQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance at GAS
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Expression of Kv1.3 channel protein in Treg cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of aldosterone in blood circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Levels of IL-10 and TGF-β in blood circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recognition ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRc rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRc MRD negative rate by flow cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRc MRD negative rate by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in numerical grade of dysplastic lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With clinically significant Abnormal Laboratory Values and/or Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Gut Permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Accuracy of Predicting Spread Through Air Spaces (STAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response rate for SLE response index 4 (SRI4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who achieved renal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of subjects who achieved lupus low disease activity state (LLDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MMP-9 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in NGAL Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specified symptom sum score/scale, roughness, redness, crack (SRRC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptom burden related to primary or metastatic central nervous system tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful completion of treatment without grade 3-4 oesophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of HLA sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of EPIC score for the gastrointestinal domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of EPIC score for the genitourinary domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Early detection of hepatocellular carcinoma (HCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Amplitude of coding of complex and ecological sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spectrum of coding of complex and ecological sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of clinically assessed cure or transition to suppressive antimicrobial therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Self-reported Cue-elicited Drug Craving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Ambient Drug Craving Over Time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device-related Serious Adverse Event Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Participant satisfaction with the SparkRx app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mGFR relative to kidney volume (scintigraphy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Whole-kidney GFR (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of glomerular hyperfiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of GDX012
Endpoint domain: Physiological/clinical
Primary endpoint: Cesarean section rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Phase Coordination Index (PCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor fatigability during the 6 minutes condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 6 minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of salivary melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Safety and tolerability of Alveavax-v1.2
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of initial lung cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian reserve status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in food purchase behaviour based on the Healthy Trolley Index (HETI)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in food purchase behaviour based on the Grocery Purchase Quality Index (GPQI)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in food purchase behaviour based on food groups
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in food purchase behaviour based on nutrition facts
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in food purchase behaviour based on the Nutri-Score
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of Participants With Suicidal Ideation or Suicidal Behavior as Recorded on the Columbia-Suicide Severity Rating (C-SSRS) Scale
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of Cancer Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Evaluation of Treatment Response to Palbociclib and Bevacizumab Combination Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in fat fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fibrosis in the heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in LVEF/GLS-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dose 1 Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized Height Velocity (AHV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of fresh frozen plasma transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility of Imaging Technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of Imaging Technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality during ICU stay
Endpoint domain: Mortality/survival
Primary endpoint: Modified Driving Performance Examination (MDPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advanced Roadside Impaired Driving Enforcement (ARIDE) battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug Recognition Expert (DRE) evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in radiolucent volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission to the Emergency Department
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average Change in Sedentary Duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CPR-AED knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR-AED maneuvers in simulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of coronary CT angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of BAFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lupus Clinical Manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Box and Blocks test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clavicle length measurement in third trimester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep improvement efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Visual Analogue Scale (VAS) Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence rate of axial length shortening >0.05 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SSI Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative complications of grade II or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Student scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gross Motor Function Measurement-88 (GMFM-88)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation and Environment Measure for Children and Youth (PEM-CY)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Successful nasal intubation at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mRNA levels of EKLF gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Perception of work ability-productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Neuropsychiatric Inventory-Severity/Distress scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Caregiver Strain Index
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Recovery of forced expiratory volume in 1 second (FEV 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain assessment using Wong Baker Facial Pain Rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early detection of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes